June 18, 2014 — Distinguished physicians from leading cardiac surgery centers gathered at an educational symposium to share their experiences with a new-generation blood evacuation system for use following cardiothoracic surgical procedures. ClearFlow Inc. hosted the symposium at the recent American Association of Thoracic Surgeon’s meeting in Toronto, Canada, where its award-winning technology was on exhibit for more than 2,400 cardiac surgeons and healthcare professionals.
Marc Gillinov, M.D., a surgeon from the Cleveland Clinic, discussed the incidence and consequences of the complications that can result from the incomplete evacuation of blood from a patient’s chest after cardiac surgery. Louis Perrault, M.D., from Montreal Heart Institute described the lack of best practices regarding the maintenance of chest tube patency after surgery, and discussed the opportunity for implementing new protocols to enhance patient care in this area. Brian Bruckner, M.D., shared the unique needs of ventricular assist device (VAD) patients with respect to managing their post-operative bleeding. “It was exciting to hear these esteemed physicians share their positive experiences with the PleuraFlow Active Clearance Technology,” stated the panel moderator and company founder and chairman, Edward Boyle, M.D.
“At the heart of our mission is a goal to dramatically reduce the common occurrence of chest tube occlusion that leads to death and injury in this patient population,” said ClearFlow president & CEO, Paul Molloy. “Patients are experiencing unnecessary pain and additional procedures and most hospitals are shouldering the burden of extensive cost increases due to lack of consistent protocols and unacceptable failure with current products used for wound drainage post-cardiac surgery.”
For more information: www.clearflow.com
March 20, 2024 
